Medtronic Inc. (MDT): Today's Featured Health Services Winner

Medtronic ( MDT) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.6%. By the end of trading, Medtronic rose $0.88 (1.7%) to $52.41 on light volume. Throughout the day, 3,650,175 shares of Medtronic exchanged hands as compared to its average daily volume of 5,012,000 shares. The stock ranged in a price between $51.85-$52.42 after having opened the day at $51.87 as compared to the previous trading day's close of $51.53. Other companies within the Health Services industry that increased today were: Universal American ( UAM), up 7.0%, Hooper Holmes ( HH), up 6.2%, AngioDynamics ( ANGO), up 5.4% and RTI Biologics ( RTIX), up 5.0%.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $52.2 billion and is part of the health care sector. Shares are up 25.6% year to date as of the close of trading on Wednesday. Currently there are 9 analysts that rate Medtronic a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Pingtan Marine Enterprise ( PME), down 63.3%, SunLink Health Systems ( SSY), down 10.1%, USMD Holdings ( USMD), down 8.7% and BG Medicine ( BGMD), down 4.9% , were all laggards within the health services industry with Universal Health Services ( UHS) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Medtronic Looks Vulnerable to a Bigger Decline

FDA Approves Abbott Heart Device, Stock Rises

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Cramer: This Rally Isn't Without Meaning